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ABSTRACT 
 
Background: Although community-acquired pneumonia (CAP) is a common and well-known disease, its 
microbial aetiology is still not well characterized. During the past few years nucleic acid detection using real-
time polymerase chain reaction (PCR) has been developed for detection of many bacterial and viral pathogens 
causing respiratory tract infections. 
 
Objectives: 1) to estimate the accuracy of the quantitative real-time PCR (RQ-PCR) method for identifying 
pneumococci in sputum; 2) to determine the aetiology of CAP by implementing new diagnostic PCR techniques 
combined with conventional methods; 3) to compare CAP patients with a pure bacterial aetiology with those 
with both bacterial and viral findings regarding severity of illness and length of hospital stay; 4) to study the 
inflammatory response, especially procalcitonin (PCT) levels, in patients with CAP and the correlation to 
different respiratory pathogens. 
 
Material and methods: Adults admitted to Karolinska University Hospital were studied during a 12-month 
period. All patients were tested with an extensive panel of conventional methods and in addition sputum 
samples were analysed with RQ-PCR for Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella 
catarrhalis; and nasopharyngeal specimens were analysed with real-time PCR for viruses common in the 
airways. Serum samples were collected within 24 hours of admission for subsequent measurement of PCT, C-
reactive protein, transthyretin and interleukin-6. The pneumonia severity index (PSI) was used to assess the 
severity of illness. 
 
Results: In sputum samples, culture was significantly positive in 19/128 (15%), whereas a significant 
concentration of DNA was found with RQ-PCR in 34/127 (27%) cases (p < 0.001). Seventeen of the 34 RQ-
PCR–positive sputum samples were negative by sputum culture, of which 14 were from patients treated with 
antibiotics prior to sampling. A microbial aetiology was found in 67% of all patients (n=124). The most 
frequently detected pathogens were S. pneumoniae (70 patients [38%]) and respiratory virus (53 patients 
[29%]). Multiple pathogens were present in 43 (35%) of those with a determined aetiology. The likelihood of 
getting a score corresponding to PSI classes IV or V was higher in patients with combined bacterial-viral 
findings than in those with a bacterial pathogen alone (odds ratio 4.98, 95% confidence interval 2.09 – 11.89; p 
< 0.001). The median length of hospital stay was seven days among patients with mixed infections and four 
days among those with a bacterial aetiology alone (p=0.018). Median serum concentrations of PCT were higher 
in patients with bacteraemia than in those without bacteraemia (6.11 µg/L vs. 0.34 µg/L, P=0.0002), in those 
with non-bacteraemic pneumococcal aetiology than in those infected with other classic bacteria (1.18 vs. 0.18, 
P=0.038), in patients with pneumococcal as compared to viral aetiology (2.43 vs. 0.24, P=0.017), and in patients 
with PSI classes 4-5 (2.07) than in those with PSI classes 1-3 (0.52, P=0.03). 
 
Conclusions: The sensitivity of sputum RQ-PCR was higher than that of sputum culture, especially after 
antibiotic therapy had been initiated. By supplementing traditional diagnostic methods with new PCR-based 
methods, a high microbial yield was achieved. Mixed bacterial-viral infections were frequent and these patients 
developed severe CAP more often and stayed longer in hospital than those with a bacterial aetiology alone. High 
PCT seems to be a good marker of invasive as well as severe disease and of pneumococcal aetiology, but for 
localised bacterial infections caused by other pathogens the test is less sensitive. 
 
 
 
ISBN 978-91-7457-951-2 
 
